ORIGINAL RESEARCH article

Front. Public Health, 24 October 2023

Sec. Public Health Education and Promotion

Volume 11 - 2023 | https://doi.org/10.3389/fpubh.2023.1180907

Influence of pelvic floor disorders on quality of life in women

  • 1. Department of Nursing, University of Jaén, Jaén, Spain

  • 2. Department of Nursing, Physiotherapy and Occupational Therapy, Faculty of Nursing, University of Castilla la Mancha, Ciudad Real, Spain

  • 3. Epidemiology and Public Health CIBER (CIBERESP), Madrid, Spain

Abstract

Objective:

To determine whether the different pelvic floor disorders are associated with changes in perceived quality of life (QoL), globally and in its sub-dimensions.

Methods:

An observational study was conducted with women in Spain between 2021 and 2022. Information was collected using a self-developed questionnaire on sociodemographic data, employment, history and health status, lifestyle and habits, obstetric history, and health problems. The SF-12 questionnaire was used to assess quality of life. The Pelvic Floor Distress Inventory (PFDI-20) was used to assess the presence and impact of pelvic floor problems, and includes the POPDI-6 subscales for prolapse, CRADI- 8 for colorectal symptoms, and UDI-6 for urinary symptoms. Crude (MD) and adjusted mean differences (aMD) were estimated with their respective 95% confidence intervals (CI).

Results:

Thousand four hundred and forty six women participated in the study with a mean age of 44.27 (SD = 14.68). A statistical association was observed between all the pelvic floor disorders and QoL, overall and in all its dimensions (p <0.001), in the bivariable analysis. The lowest scores were observed in the emotional component. After adjusting for confounding factors, the pelvic floor disorders in general (aMD −0.21, 95% CI: −0.23 to −0.20), the impact of uterine prolapse symptoms (aMD −0.20, 95% CI: −0.27 to −0.12), the colorectal-anal symptoms (aMD −0.15, 95% CI: −0.22 to −0.09), and urinary symptoms (aMD −0.07, 95% CI: −0.13 to −0.03) was negatively associated on the score on the SF-12 questionnaire (p <0.05).

Conclusions:

Women who have a pelvic floor dysfunction, symptoms of pelvic organ prolapse, colorectal-anal symptoms, or urinary symptoms, have a worse perceived quality of life in all dimensions. Prolapse symptoms have the biggest impact, and the emotional component of QoL is the most affected sub-domains.

Introduction

Pelvic floor disorders are a public health problem, with their prevalence reaching 25% in the US in healthy non-pregnant women. It is a problem present in all age ranges, although occurs more in older women (, ). Hence, it is estimated that one in nine women will require surgical intervention for this problem at some point in their life. Pelvic floor disorders encompass clinical disorders related to urinary incontinence, pelvic organ prolapse, fecal incontinence, and pelvic-perineal pain syndrome ().

Recent studies have identified that the presence of these pelvic floor disorders and the impact of their symptoms reduce health-related quality of life (HRQoL) in women; likewise, they have direct negative consequences on physical, psychological, sexual, and social health (). These disabling problems lead to social isolation, affect the performance of tasks, cause loss of personal and intimate relationships, and reduce participation in leisure activities ().

The World Health Organization (WHO) defines “Quality of Life as an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns” (). HRQoL has become a fundamental indicator when evaluating health care and reflects a person's physical, psychological, social, and emotional wellbeing (, ). Measuring HRQoL is a challenge for researchers as it is a subjective, individual term that evolves over time (). However, a low HRQoL score can be used to predict physical deterioration, resource consumption rates, hospital admissions, and even mortality (, ). There is evidence that women report lower HRQoL scores than men ().

The scores obtained in previous HRQoL research differ depending on sociodemographic, socioeconomic, and gender characteristics, among others (, ). In addition, some studies have shown that a low HRQoL score has been associated with modifiable factors such as lifestyle (), physical exercise (), being overweight (), sleep quality (), among others.

The impact of pelvic floor disorders and their symptoms on HRQoL in women has been studied with inconclusive results; however, not all disorders have been considered, and most of the studies were carried out around the perinatal stage, ignoring other stages of a woman's life (, ). The prevalence of these disorders demonstrates their presence in a high number of women. As such, the repercussion on health and other aspects such as quality of life is substantial and pushes it to the frontline as a public health and women's health problem that needs to be addressed (). For this reason, the objective of the present study is to determine whether the different pelvic floor disorders are associated with changes in perceived quality of life, globally and in its sub-dimensions, with the aim that professionals can take these into account in their clinical practice and prioritize the most appropriate interventions.

Materials and methods

Design and subject selection

This observational study was carried out during 2021 and 2022 in Spain. Exclusion criteria were: difficulty understanding Spanish, women under 18 years of age, having a mental and/or cognitive disorder that may affect data collection, and having given birth in the last 12 months or were pregnant.

To carry out this study it was necessary to recruit a minimum sample of 890 women based on the following criteria: a confidence level of 95%, an absolute precision error of 3%, a population prevalence of pelvic floor problems of around 25% (), and a percentage of losses of 10%.

Information sources and study variables

The investigation was publicized by places that women frequented: women's associations, information centers as well as health centers. When the women expressed their interest in participating, their informed consent was obtained, after which trained observers interviewed them to obtain sociodemographic and employment data, previous medical history and health status, lifestyle and habits, obstetric history, and health problems using a previously piloted self-made questionnaire. The women were recruited consecutively,

Next, the women's quality of life was assessed using the SF-12 questionnaire (). This questionnaire consists of a set of 12 items on HRQoL, and considers physical functioning through 6 items and, another 6 items to assess the state of perceived mental health. The SF-12 version presents eight domains: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. The total quality of life score is obtained from the sum of the two subscales, physical health, and mental health, on a scale from 0 to 100, with a higher score indicating a better perceived HRQoL. The value 50 (SD = 10) is the general population's mean values, higher or lower than this are interpreted as better or worse quality of life, respectively ().

Next, to assess the presence and impact of pelvic floor disorders, the Pelvic Floor Distress Inventory (PFDI-20) was used (, ). The PFDI-20 includes 20 items divided into 3 symptom scales: symptoms of pelvic organ prolapse (POPDI-6) (questions 1 to 6); colorectal-anal symptoms (CRADI-8) (questions 7–14); and urinary symptoms (UDI-6) (questions 15–20). To determine the prevalence of the different disorders, the following key questions/items were used: Regarding the prevalence of prolapse, the criterion of symptomatic prolapse was used by means of an affirmative answer in item 3; for fecal incontinence, the sum of affirmative answers in items 9 and 10 was used as a criterion; for urinary incontinence, the sum of affirmative responses to items 16 and 17; while for the prevalence of pelvic pain, the affirmative response to item 20 was used. Each question used a 0–4 response format, categorizing the dysfunction in 4 levels: none, little, moderate, a lot. The minimum score for each subscale is 0, and the maximum is 100 points, referring to minimum and maximum dysfunction. The total score of the PFDI-20 is the sum of the three subscales, with a maximum score of 300.

Next, the short version of the International Physical Activity Questionnaire (IPAQ) was used to determine the level of physical activity (). The IPAQ classifies adult populations based on activity levels (low, moderate, and high). This questionnaire has adequate validity. A low level of physical or inactive activity was considered when 600 METs (Physical Activity Unit of the Test) were not reached.

Finally, to assess the quality of sleep, the validated Pittsburgh Sleep Quality Index (PSQI) () was used, which comprises 19 self-assessed questions. Based on these questions, seven components were elaborated that evaluated different aspects of sleep quality: subjective sleep quality, sleep latency, sleep time, total sleep efficiency, sleep disorders, consumption of hypnotic drugs, and daytime dysfunction. The scores for each question range from 0 to 3 points, with 0 corresponding to the absence of a problem, and 3 with a severe sleep problem. Finally, to determine the scale's total score, the scores of these components are summed, resulting in a minimum score of 0 points and a maximum of 21 points. Participants with a total score of 0 to 4 were considered to have good sleep quality, and scores equal to or >5 are interpreted as poor sleep quality ().

Statistical analysis

SPSS 28.0 was used for the analysis of the information. First, descriptive statistics were carried out using absolute and relative frequencies, and means with standard deviation (SD) for continuous variables.

Next, a bivariable analysis was performed between the pelvic floor disorders (urinary and fecal incontinence, prolapse, and pain) and the sub-dimensions of the SF-12 quality of life questionnaire using the Student-Fisher t-test. In addition, the relationship between the impact of symptoms through the PFDI-20 scale and its subscales POPDI-6, CRADI-8, and UDI-6 with the different dimensions of the SF-12 questionnaire was analyzed by means of linear regression.

Finally, we performed bivariable and multivariable analyses using multiple linear regression between the three subscales of the impact of pelvic floor dysfunction symptoms and quality of life. To do this, we adjusted for age, physical activity, sleep quality, the existence of menopause, body mass index (BMI), and the presence of different comorbidities. In all cases, mean differences (MD) with their respective 95% confidence intervals (95% CI) were estimated.

Ethical considerations

The study received a favorable opinion from the Research Ethics Committee of the province Jaén, reference number SPCV-0220/0302-N-20. Before starting the questionnaire, the women had to read an information sheet about the study and its objectives and confirm their consent to participate in it.

Results

A total of 1446 women participated. Their mean age was 44.27 years (SD = 14.68), with a mean BMI of 25.00 (SD = 4.75). Regarding civil status, 57.3% (828) were married. In terms of lifestyle, 14.3% (207) of the sample smoked, 54.4% (786) drank alcohol occasionally, and 35.4% (512) had a median income level of 1,000–1,999 euros.

Regarding personal and obstetric history, 28.9% (418) were in menopause, 33.0% (477) had some type of illness, of which 6.4% (93) were musculoskeletal conditions. Urinary incontinence was present in 55.8% (807) of participants, and 18.7% (271) had pelvic pain. In addition, 78.2% (1131) had been pregnant at least once. Regarding the type of delivery, 67.2% (971) had experienced a vaginal birth and 26.2% (379) an instrumental one (Table 1).

Table 1

Variablen (%)Mean (SD)
Age44.27 (14.68)
< 30 years220 (15.2)
30–49.9 years799 (55.3)
≥50427 (29.5)
BMI25.00 (4.75)
Normal weight < 24.99830 (57.4)
Overweight 25–29.9405 (28.0)
Obesity ≥ 30211 (14.6)
Civil status
Single334 (23.1)
Separated19 (1.3)
Divorced73 (5.0)
Widowed67 (4.6)
Common-law couple125 (8.6)
Married828 (57.3)
Employment sector
Administration126 (8.7)
Agriculture/livestock29 (2.0)
Commerce59 (4.1)
Student105 (7.3)
Industry and construction54 (3.7)
Retired165 (11.4)
Self-employed168 (11.6)
Public servant740 (51.2)
Income level
< 1,000 euros196 (13.6)
1,000–1,999 euros512 (35.4)
2,000–2,999 euros425 (29.4)
>3,000 euros313 (21.6)
Alcohol consumption
Never351 (24.3)
Occasionally786 (54.4)
Only weekends144 (10.0)
Frequently142 (9.8)
Daily23 (1.6)
Smoking habit
No1239 (85.7)
Yes207 (14.3)
Pregnancy
None315 (21.8)
One194 (13.4)
Two or more937 (64.8)
Vaginal birth
None475 (32.8)
One289 (20.0)
Two or more682 (47.2)
Instrumental birth
No1067 (73.8)
Yes379 (26.2)
Tear
No904 (62.5)
Yes542 (37.5)
Menopause
No1028 (71.1)
Yes418 (28.9)
Illness
No969 (67.0)
Yes477 (33.0)
Cardiovascular disorder
No1244 (86.0)
Yes123 (8.5)
Respiratory disorder
No1329 (91.9)
Yes38 (2.6)
Endocrine disorder
No1219 (84.3)
Yes148 (10.2)
Gynecological disorder
No1325 (91.6)
Yes42 (2.9)
Musculoskeletal disorder
No1274 (88.1)
Yes93 (6.4)
Neurological disorder
No1333 (92.2)
Yes34 (2.4)
Neoplastic disease
No1355 (93.7)
Yes12 (0.8)
Gastrointestinal disorder
No1325 (91.6)
Yes42 (2.9)
Dermatological disorder
No1345 (93.0)
Yes22 (1.5)
Mental illness
No1342 (92.8)
Yes25 (1.7)
Nephro-urological disorder
No1357 (93.8)
Yes10 (0.7)
Immunological disorder
No1356 (93.8)
Yes11 (0.8)
Ophthalmo-ENT disorder
No1342 (92.8)
Yes25 (1.7)
Urinary incontinence
No639 (44.2)
Yes807 (55.8)
Fecal incontinence
No1296 (89.6)
Yes150 (10.4)
Prolapse
No1243 (86.0)
Yes203 (14.0)
Pelvic pain
No1175 (81.3)
Yes271 (18.7)

Sociodemographic and clinical characteristics of the study sample.

Table 2 shows the response distribution of HRQoL according to the SF-12 questionnaire, as well as the dimensions that evaluated the domains of physical and mental health. Of note, 50.9% (736) of the women reported alterations in the vitality domain, which was the most affected dimension with a mean score of 52.72 (SD = 23.49). In addition, 15.3% (221) of the women rated their perceived general health as low, with a mean score of 55.43 (SD = 19.28). In general, in the total SF-12, 16.5% (239) of the participating women presented altered HRQoL, with a mean score of 69.51 (SD = 20.09).

Table 2

Dimension scores SF-12n (%)Mean (SD)
Physical function85.29 (25.91)
>501350 (93.4)
< 5096 (6.6)
Physical role71.85 (40.83)
>501142 (79.0)
< 50304 (21.0)
Body pain80.53 (25.82)
>501311 (90.7)
< 50135 (9.3)
Vitality52.72 (23.49)
>50710 (49.1)
< 50736 (50.9)
Social function75.05 (25.56)
>501210 (83.7)
< 50236 (16.3)
Emotional role60.55 (46.00)
>50955 (66.0)
< 50491 (34.0)
Mental health74.63 (16.96)
>501351 (93.4)
< 5095 (6.6)
General health55.43 (19.28)
>501225 (84.7)
< 50221 (15.3)
SF-12 total69.51 (20.09)
>501207 (83.5)
< 50239 (16.5)

Distribution of responses to the HRQoL questionnaire SF-12.

Next, the bivariable analysis in Table 3 shows the relationship between pelvic floor disorders and HRQoL using the SF-12 questionnaire. This analysis observed a significant association in all cases (p <0.05). Specifically, regarding women who have urinary incontinence, the most affected dimension was vitality, with a mean score of 50.68 (SD = 23.16). Whereas, for women who have fecal incontinence, the most affected domain was the emotional role, with a mean score of 40.67 (SD = 45.39). Regarding women with uterine prolapse, the most affected dimension was vitality, showing a mean score of 45.02 (SD = 23.64). For women with pelvic pain, the most altered domain was the emotional role, with a score of 40.59 (SD = 46.09). Finally, as shown by the scores in the table, it was reported that the mental component was always the most affected in all pelvic floor disorders.

Table 3

SF-12 dimensionsUrinary incontinenceFecal incontinenceProlapsePelvic pain
No (n = 639)Yes (n = 807)Sig.No (n = 1296)Yes (n = 150)Sig.No (n = 1243)Yes (n = 203)Sig.No (n = 1175)Yes (n = 271)Sig.
Physical functionMean (SD)90.73 (20.07)80.98 (29.03)< 0.00187.77 (22.53)63.83 (39.77)< 0.00187.21 (24.02)73.52 (33.06)< 0.00188.45 (22.77)71.59 (33.26)< 0.001
Physical roleMean (SD)79.10 (35.82)66.11 (43.58)< 0.00174.85 (39.05)46.00 (46.53)< 0.00174.62 (39.28)54.93 (45.87)< 0.00177.66 (37.61)46.68 (44.59)< 0.001
Body painMean (SD)86.66 (21.44)75.68 (27.89)< 0.00182.64 (24.22)62.33 (31.56)< 0.00182.18 (24.86)70.44 (29.13)< 0.00183.98 (23.73)65.59 (29.01)< 0.001
VitalityMean (SD)55.31 (23.66)50.68 (23.16)< 0.00153.78 (23.26)43.60 (23.52)< 0.00153.98 (23.23)45.02 (23.64)< 0.00155.30 (23.20)41.55 (21.41)< 0.001
Social functionMean (SD)77.65 (24.46)72.99 (26.22)0.00176.77 (24.36)60.13 (30.43)< 0.00176.12 (24.89)68.47 (28.48)< 0.00177.99 (24.20)62.29 (27.36)< 0.001
Emotional roleMean (SD)64.32 (44.91)57.56 (46.65)0.00562.85 (45.52)40.67 (45.39)< 0.00162.71 (45.39)47.29 (47.51)< 0.00165.15 (44.74)40.59 (46.09)< 0.001
Mental healthMean (SD)77.73 (14.93)72.18 (18.04)< 0.00175.94 (15.93)63.33 (20.97)< 0.00175.66 (16.43)68.37 (18.74)< 0.00177.12 (15.60)63.84 (18.36)< 0.001
General healthMean (SD)59.12 (18.09)52.51 (19.71)< 0.00156.71 (18.83)44.33 (19.68)< 0.00156.32 (18.83)50.00 (21.11)< 0.00172.91 (17.88)54.76 (22.41)< 0.001
SF-12 totalMean (SD)73.73 (17.15)66.09 (21.55)< 0.00171.41 (18.65)53.03 (24.23)< 0.00171.10 (19.12)59.76 (22.99)< 0.00172.90 (17.88)54.76 (22.41)< 0.001

SF-12 Quality of life questionnaire and the sub-dimensions related to pelvic floor dysfunction. Bivariate analysis.

Bold numerical values are statistically significant values.

Next, Table 4 shows the analysis of the relationship between the impact of pelvic floor symptoms and perceived quality of life, with a statistical association observed with all four scales (p < 0.05). Overall, it was concluded that for each point of variation of the PFDI scale there is a reduction of 0.21 points in the SF-12 quality of life questionnaire, MD −0.21, 95% CI: −0.23 to −0.20. Of note, the symptoms of prolapse are the ones that most affect the assessment of quality of life, causing a decrease of 0.57 points in the total score of the SF-12 for each point of variation in the POPDI-6 subscale, MD −0.57, 95% CI: −0.62 to −0.51.

Table 4

VariableSF-12 total
Score impact of pelvic floor problemsMD (95% CI)P-value
Prolapse symptoms (POPDI-6)−0.57 (−0.62 to −0.51)< 0.001
Colorectal-Anal symptoms(CRADI-8)−0.54 (−0.60 to −0.49)< 0.001
Urinary symptoms (UDI-6)−0.39 (−0.43 to −0.34)< 0.001
Pelvic function disorders Total (PFDI-20)−0.21 (−0.23 to −0.20)< 0.001

Relationship between the impact of pelvic floor symptoms and quality of life.

Bold numerical values are statistically significant values.

Finally, a multivariable analysis was carried out, as shown in Table 5. In this analysis, the different sociodemographic variables, lifestyles, obstetric variables, personal history, and the different pelvic floor disorders and their impact were related to the total SF-12 questionnaire score. Being aged between 30 and 50 years and the performance of physical exercise, as evaluated by the IPAQ questionnaire, produced an improvement in the result of the total SF-12 with a MD of 4.82 points, 95% CI: 2.44–7.20 and 0.001 points, 95% CI: 0.001–0.001, respectively. On the other hand, when the BMI increased, the SF-12 score decreased, with a MD of −0.36 points, 95% CI: −0.54 to −0.17. Likewise, it was reported that women who had certain conditions had reduced HRQoL, namely musculoskeletal, MD −9.32, 95% CI: −13.03 to −5.62, neoplastic diseases MD −13.99, 95% CI: −23.10 to −4.88, and mental health illnesses MD −8.47, 95% CI: −14.70 to −2.42. Finally, the intensity of the impact of the symptoms of pelvic floor disorders, as assessed by the subscales, significantly decreased HRQoL: POPDI-6: MD −0.20, 95% CI: −0.27 to −0.12, CRADI-8: MD −0.15, 95% CI: −0.22 to −0.09 and UDI-6: MD −0.07, 95% CI: −0.13 to −0.03.

Table 5

Bivariable analysis SF-12 totalMultivariable analysis SF-12 total
VariableMD (95% CI)P-valueMD (95% CI)P-value
Age 30–50 years (Ref Cat < 30 years)2.27 (–0.68 to 5.22)0.1324.82 (2.44 to 7.20)< 0.001
Age ≥ 50 years. (Ref Cat < 30 years)−6.15 (–9.36 to−2.93)< 0.0013.37 (−0.92 to 7.67)0.123
BMI (for each point)−1.02 (−1.23 to −0.80)< 0.001−0.36 (−0.54 to −0.17)< 0.001
Menopause (Ref Cat No)−6.87 (−9.18 to −4.56)< 0.001−2.49 (−5.79 to 0.82)0.140
Cardiovascular condition (Ref Cat No)−16.86 (–20.50 to −13.22)< 0.001−3.21 (−6.56 to 0.13)0.060
Pulmonary condition (Ref Cat No)−10.77 (−17.28 to −4.25)0.001−1.67 (−6.71 to 3.37)0.515
Endocrine condition (Ref Cat No)−8.53 (−11.94 to −5.12)< 0.001−2.49 (−5.15 to 0.180)0.068
Gynecology condition (Ref Cat No)−9.06 (−15.34 to −2.78)0.005−4.11 (−8.98 to 0.76)0.098
Musculoskeletal condition (Ref Cat No)−23.95 (−27.99 to −19.92)< 0.001−9.32 (−13.03 to −5.62)< 0.001
Neurological condition (Ref Cat No)−17.13 (−23.88 to −10.38)< 0.001−5.28 (−10.62 to −0.059)0.053
Neoplastic condition (Ref Cat No)−22.94 (−34.75 to −11.13)< 0.001−13.99 (−23.10 to −4.88)0.003
Gastrointestinal condition (Ref Cat No)−13.66 (−19.84 to −7.48)< 0.001−2.48 (−7.26 to 2.31)0.311
Dermatological condition (Ref Cat No)−4.16 (−12.59 to 4.27)0.334−1.42 (−7.84 to 5.00)0.664
Mental health disorder (Ref Cat No)−25.78 (−33.58 to −17.98)< 0.001−8.47 (−14.70 to −2.42)0.008
Nephro-urological condition (Ref Cat No)−11.33 (−23.76 to 1.11)0.0748.10 (−1.68 to 17.87)0.105
Immunological condition (Ref Cat No)−8.12 (−20.56 to 4.33)0.201−6.46 (−15.91 to 3.00)0.180
Ophthalmological-ENT condition (Ref Cat No)−20.17 (−28.35 to −12.00)< 0.001−2.67 (−9.34 to 4.00)0.337
IPAQ (for each point) (Ref Cat No)0001 (0.001–0.002)< 0.0010.001 (0.001–0.001)< 0.001
PSQI Total (for each point)−2.51 (−2.73 to −2.28)< 0.001−1.57 (−1.79 to −1.35)< 0.001
Impact prolapse symptoms (for each point)−0.57 (−0.62 to −0.51)< 0.001−0.20 (−0.27 to −0.12)< 0.001
Impact colorectal-anal symptoms (for each point)−0.54 (−0.60 to −0.49)< 0.001−0.15 (−0.22 to −0.09)< 0.001
Impact urinary symptoms (for each point)−0.39 (−0.43 to −0.34)< 0.001−0.07 (−0.13 to −0.03)0.004

Variable and multivariate analysis. Quality of life and associated factors.

Bold numerical values are statistically significant values.

Discussion

Pelvic floor disorders and the impact of their symptoms negatively influence the HRQoL of women. Having an age between 30 and 50 years and physical exercise were related to better HRQoL scores. Other factors were negatively related to women's quality of life, such as: a high BMI, and poor sleep quality. Finally, having a musculoskeletal condition, neoplastic pathology, or mental health illness was also negatively associated with the perceived quality of life.

We highlight as strengths of the study, a priori, the study's sample size, and as a novel aspect the inclusion of all pelvic floor disorders that have previously not been collectively included by other authors. On the other hand, possible limitations include the use of questionnaires for data collection as they may result in selection and memory biases. These biases were considered, and to control it, the questionnaire was previously piloted and elaborated in an adapted language that was easy to read and understand at all educational levels. Another limitation of the study is the non-inclusion of non-Spanish speaking women, as it was not pragmatic to use translators for each of the possible languages. In the same way, an attempt was made to avoid confounding bias, both through the selection of the participants, which was based on defined inclusion criteria defined, and the multivariable analysis, including in the model all those variables that could influence the results obtained, such as age, BMI, background, among others. On the other hand, although a clinical evaluation of pelvic floor dysfunction was not carried out through clinical diagnostic means, the instruments used were questionnaires validated (, ) in a population similar to that of our study and are widely accepted on an international level as instruments to detect possible pelvic floor dysfunction (). Likewise, all the other instruments used to measure the different parameters have been validated and previously used in a population similar to that of this study (, ).

Our results detected an association between age and quality of life, as established by other researchers (4749). It is important to highlight that the distribution of scores related to quality of life between age groups varies; thus, in line with most of the literature, older age ranges were associated with worse quality of life scores. For example, a longitudinal study carried out in Australia on health and wellbeing included data on 16006 women in three age cohorts and showed a reduction in the scores of the physical component and the mental component throughout the life of the women, negatively influencing age in their older age cohort (48).

The negative impact of BMI identified in our study was also found by García Mendizábal et al. Their study in Spain, which included 1298 women between the ages of 18 and 60, found lower scores for HRQoL as BMI increased (50). This association was also identified by other authors (51).

The presence of specific pathologies negatively influences quality of life. Concerning musculoskeletal pathologies, in line with our results, a study with a nationally representative sample of 17550 participants carried out in the United States, where the same evaluation method was used as in our study, affirmed that those who had musculoskeletal conditions had lower HRQoL scores (52). Likewise, neoplastic diseases, as shown by our results and by other authors (53), are negatively associated with HRQoL. This was also identified in a sample of 1078 women diagnosed with breast cancer in a multi-case control study carried out in Spain, which rated their HRQoL as poor (54).

Another variable that was identified as influencing HRQoL was sleep quality. A longitudinal study in the United Kingdom comprising 30594 participants, of whom 20003 were women, stated that a good quality of sleep was directly and positively related to the quality of life of women (55). In our results, the worse the quality of sleep, the lower the quality of life score.

Regarding the physical activity variable, the results of our study found a positive relationship with better perceived health; the greater the physical activity, the higher the quality of life score. These findings coincide with those in existing literature (56, 57). In Poland, an observational analytical study with a sample size of 598 participants (299 women and 299 men) implemented a physical activity program and demonstrated that the women who performed the program subjectively improved their HRQoL (57).

In relation to mental health, a study carried out in the USA (5719 participants, 48.07% of the population women) found that a depressive state influences how individuals perceive their state of health and wellbeing (58), in agreement with our results and those of other authors (59, 60).

In line with some researchers, it was identified that pelvic floor dysfunction influenced HRQoL (). Specifically, a cross-sectional study carried out in Brazil, including 556 women, identified that all types of urinary incontinence influence women's general quality of life (). Similarly, a study with 732 enrolled women showed that quality of life was substantially affected in patients with fecal incontinence (), in line with other authors ().

On the other hand, in relation to pelvic pain, Ahangari, in a systematic review, only found seven articles with different types of research (cross-sectional, community study, etc.) that addressed this disorder. This systematic review found that this problem affects different dimensions of the women's quality of life, as has also happened in our results (61). Finally, coinciding with what we have identified, an observational analytical study made up of 357 women carried out in Bangladesh found an association between uterine prolapse and related factors and HRQoL (), as was also determined by other authors ().

It is necessary to consider HRQoL in women with pelvic floor disorders and who experience the impact of their symptoms in order to be able to implement the necessary measures to address it so that these women can have a better perception of their health on a physical, mental and social level. For this reason, providing greater visibility to this problem experienced by many women will make it possible to implement controls and monitoring at all levels to detect these conditions and provide early care with adequate and effective treatment.

Conclusions

Women with pelvic floor disorders have a worse perceived quality of life in all dimensions, with prolapse symptoms having the biggest impact, and the emotional component being the most affected sub-domain of HRQoL.

Statements

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics statement

The studies involving humans were approved by the study received a favorable opinion from the Research Ethics Committee of the province of Jaen, SPCV-0220/0302-N-20. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Funding

This project was co-funded by the Operative Program FEDER 2014-2020, and Ministry of Economics and Knowledge of the Government of Andalucia [1380358]. RP received a Grant from the Program University Teacher Training financed by the Ministry of Universities Government of Spain [FPU20/01567].

Acknowledgments

The authors thank all the women that participated in this study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.

    WuJMVaughanCPGoodePSReddenDTBurgioKLRichterHEet al. Prevalence and trends of symptomatic pelvic floor disorders in US women. Obstet Gynecol. (2014) 123:1418. 10.1097/AOG.0000000000000057

  • 2.

    HongMKDingDC. Current treatments for female pelvic floor dysfunctions. Gynecol Minim Invasive Ther. (2019) 8:143. 10.4103/GMIT.GMIT_7_19

  • 3.

    Al-BadrASaleemZKaddourOAlmosaieedBDawoodAAl-TannirMet al. Prevalence of pelvic floor dysfunction: a Saudi national survey. BMC Womens Health. (2022) 22:27. 10.1186/s12905-022-01609-0

  • 4.

    Pérez RodriguezNMMartínez TorresJCGarcía DelgadoRodríguez AdamsEMRodríguez LaraH. Dysfunction of pelvic and sexual floor in women. Invest Medicoquir. (2019) 11:125. Available online at: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=86706

  • 5.

    GoodMMSolomonER. Pelvic floor disorders. Obstet Gynecol Clin North Am. (2019) 46:52740. 10.1016/j.ogc.2019.04.010

  • 6.

    LaakkonenEKKulmalaJAukeePHakonenHKujalaUMLoweDAet al. Female reproductive factors are associated with objectively measured physical activity in middle-aged women. PLoS ONE. (2017) 12:e0172054. 10.1371/journal.pone.0172054

  • 7.

    ReisAMBritoLGOLunardiALBPinto e SilvaMPJuliatoCRT. Depression, anxiety, and stress in women with urinary incontinence with or without myofascial dysfunction in the pelvic floor muscles: a cross-sectional study. Neurourol Urodyn. (2021) 40:3349. 10.1002/nau.24563

  • 8.

    ZhuQShuHDaiZ. Effect of pelvic floor dysfunction on sexual function and quality of life in Chinese women of different ages: an observational study. Geriatr Gerontol Int. (2019) 19:299304. 10.1111/ggi.13618

  • 9.

    Corrêa LC deACPirkleCMWuYYVafaeiACurcioCLCâmara SMAda. Urinary incontinence is associated with physical performance decline in community-dwelling older women: results from the international mobility in aging study. J Aging Health. (2019) 31:187291. 10.1177/0898264318799223

  • 10.

    MattssonNKKarjalainenPKTolppanenAMHeikkinenAMSintonenHHärkkiPet al. Pelvic organ prolapse surgery and quality of life—A nationwide cohort study. Am J Obstet Gynecol. (2020) 222:588. 10.1016/j.ajog.2019.11.1285

  • 11.

    Cirizade.los RíosCRuiz de LeónAGarcía DuránFTomás MorosECarneros MartínJAMuñoz YagüeTet al. Calidad de vida en pacientes con incontinencia fecal y su relación con la gravedad de la misma. Gastroenterol Hepatol. (2010) 33:6218. 10.1016/j.gastrohep.2010.07.003

  • 12.

    SaboiaDMFirmianoMLVBezerra K deCVasconcelos NetoJAOriáMOBVasconcelosCTM. Impacto dos tipos de incontinência urinária na qualidade de vida de mulheres. Revista da Escola de Enfermagem da USP. (2017) 51:10. 10.1590/s1980-220x2016032603266

  • 13.

    ImotoASarkerMAkterRMatsuyamaAHondaS. Health-related quality of life in parous women with pelvic organ prolapse and/or urinary incontinence in Bangladesh. Int Urogynecol J. (2021) 32:88795. 10.1007/s00192-020-04410-5

  • 14.

    FredericeCPBritoLGOPereiraGMVLunardiALBJuliatoCRT. Interventional treatment for myofascial pelvic floor pain in women: systematic review with meta-analysis. Int Urogynecol J. (2021) 32:108796. 10.1007/s00192-021-04725-x

  • 15.

    BlanchardVNyangoh-TimohKFritelXFauconnierAPizzoferratoAC. Importance of a pelvic floor lifestyle program in women with pelvic floor dysfunctions: a pilot study. J Gynecol Obstet Hum Reprod. (2021) 50:102032. 10.1016/j.jogoh.2020.102032

  • 16.

    FialkowMFMelvilleJLLentzGMMillerEAMillerJFennerDE. The functional and psychosocial impact of fecal incontinence on women with urinary incontinence. Am J Obstet Gynecol. (2003) 189:1279. 10.1067/mob.2003.548

  • 17.

    DheresaMWorkuAOljiraLMengisteBAssefaNBerhaneY. One in five women suffer from pelvic floor disorders in Kersa district Eastern Ethiopia: a community-based study. BMC Womens Health. (2018) 18:95. 10.1186/s12905-018-0585-1

  • 18.

    The WHOQOL Group. Development of the world health organization WHOQOL-BREF quality of life assessment. Psychol Med. (1998) 28:5518. 10.1017/S0033291798006667

  • 19.

    Lizán TudelaL. La calidad de vida relacionada con la salud. Aten Primaria. (2009) 41:4116. 10.1016/j.aprim.2008.10.019

  • 20.

    Manterola DCUrrutiaSOtzen HT. Calidad de vida relacionada con salud: una variable resultado a considerar en investigación clínica. Int J Morphol. (2013) 31:151723. 10.4067/S0717-95022013000400059

  • 21.

    Jiménez BoraitaRArriscado AlsinaDDalmau TorresJMGargallo IbortE. Calidad de vida relacionada con la salud y hábitos de vida: diferencias entre adolescentes migrantes y autóctonos. Rev Esp Salud Publica. (2020) 94:202004023. 10.4321/S1135-57272020000100011

  • 22.

    SitlingerAZafarSY. Health-related quality of life. Surg Oncol Clin N Am. (2018) 27:67584. 10.1016/j.soc.2018.05.008

  • 23.

    LuoNJohnsonJAShawJWFeenyDCoonsSJ. Self-reported health status of the general adult US population as assessed by the EQ-5D and health utilities index. Med Care. (2005) 43:107886. 10.1097/01.mlr.0000182493.57090.c1

  • 24.

    HanmerJHaysRDFrybackDG. Mode of administration is important in us national estimates of health-related quality of life. Med Care. (2007) 45:11719. 10.1097/MLR.0b013e3181354828

  • 25.

    FrybackDGDunhamNCPaltaMHanmerJBuechnerJCherepanovDet al. US norms for six generic health-related quality-of-life indexes from the national health measurement study. Med Care. (2007) 45:116270. 10.1097/MLR.0b013e31814848f1

  • 26.

    CherepanovDPaltaMFrybackDGRobertSA. Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets. Qual Life Res. (2010) 19:111524. 10.1007/s11136-010-9673-x

  • 27.

    OrfilaFFerrerMLamarcaRTebeCDomingo-SalvanyAAlonsoJ. Gender differences in health-related quality of life among the elderly: the role of objective functional capacity and chronic conditions. Soc Sci Med. (2006) 63:236780. 10.1016/j.socscimed.2006.06.017

  • 28.

    KönigHHHeiderDLehnertTRiedel-HellerSGAngermeyerMCMatschingerHet al. Health status of the advanced elderly in six european countries: results from a representative survey using EQ-5D and SF-12. Health Qual Life Outcomes. (2010) 8:143. 10.1186/1477-7525-8-143

  • 29.

    JayasingheUWHarrisMFParkerSMLittJvan DrielMMazzaDet al. The impact of health literacy and life style risk factors on health-related quality of life of Australian patients. Health Qual Life Outcomes. (2016) 14:68. 10.1186/s12955-016-0471-1

  • 30.

    BrownDWBrownDRHeathGWBalluzLGilesWHFordEset al. Associations between physical activity dose and health-related quality of life. Med Sci Sports Exerc. (2004) 4:8906. 10.1249/01.MSS.0000126778.77049.76

  • 31.

    EckertK. Impact of physical activity and bodyweight on health-related quality of life in people with type 2 diabetes. Diabetes Metab Syndr Obes. (2012) 303:45. 10.2147/DMSO.S34835

  • 32.

    EdmedSLHudaMMSmithSSSeibCPorter-SteeleJAndersonDet al. Sleep and health-related quality of life in women following a cancer diagnosis: results from the Women's Wellness after Cancer Program in Australia. Support Care Cancer. (2022) 30:1024353. 10.1007/s00520-022-07429-0

  • 33.

    CarlanderAKKAndolfEEdmanGWiklundI. Health-related quality of life five years after birth of the first child. Sex Reprod Healthcare. (2015) 6:1017. 10.1016/j.srhc.2015.01.005

  • 34.

    Martínez-GalianoJHernández-MartínezARodríguez-AlmagroJDelgado-RodríguezM. Quality of life of women after giving birth: associated factors related with the birth process. J Clin Med. (2019) 8:324. 10.3390/jcm8030324

  • 35.

    VilagutGMaría ValderasJFerrerMGarinOLópez-GarcíaEAlonsoJ. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Med Clin. (2008) 130:72635. 10.1157/13121076

  • 36.

    AthanasiouSGrigoriadisTChalabalakiAProtopapasAAntsaklisA. Pelvic organ prolapse contributes to sexual dysfunction: a cross-sectional study. Acta Obstet Gynecol Scand. (2012) 91:7049. 10.1111/j.1600-0412.2012.01396.x

  • 37.

    Sánchez-SánchezBTorres-LacombaMYuste-SánchezMJNavarro-BrazálezB.Pacheco-da-CostaSGutiérrez-OrtegaCet al. Cultural adaptation and validation of the Pelvic Floor Distress Inventory short form (PFDI-20) and Pelvic Floor Impact Questionnaire short form (PFIQ-7) Spanish versions. Eur J Obstet Gynecol Reprod Biol. (2013) 170:2815. 10.1016/j.ejogrb.2013.07.006

  • 38.

    Mantilla TolozaSCGómez-ConesaA. El Cuestionario Internacional de Actividad Física. Un instrumento adecuado en el seguimiento de la actividad física poblacional Revista Iberoamericana de Fisioterapia y. Kinesiología. (2007) 10:4852. 10.1016/S1138-6045(07)73665-1

  • 39.

    Hita-ContrerasFMartínez-LópezELatorre-RománPAGarridoFSantosMAMartínez-AmatA. Reliability and validity of the Spanish version of the Pittsburgh sleep quality index (PSQI) in patients with fibromyalgia. Rheumatol Int. (2014) 34:92936. 10.1007/s00296-014-2960-z

  • 40.

    BuysseDJAncoli-IsraelSEdingerJDLichsteinKLMorinCM. Recommendations for a standard research assessment of insomnia. Sleep. (2006) 29:115573. 10.1093/sleep/29.9.1155

  • 41.

    de ArrudaGTdos Santos HenriqueTVirtuosoJF. Pelvic floor distress inventory (PFDI)—systematic review of measurement properties. Int Urogynecol J. (2021) 32:265769. 10.1007/s00192-021-04748-4

  • 42.

    DrixlerKMorfeldMGlaesmerHBrählerEWirtzMA. Validierung der Messung gesundheitsbezogener Lebensqualität mittels des Short-Form-Health-Survey-12 (SF-12 Version 20) in einer deutschen. Normstichprobe Z Psychosom Med Psychother. (2020) 66:27286. 10.13109/zptm.2020.66.3.272

  • 43.

    SandersonKAndrewsG. The SF-12 in the Australian population: cross-validation of item selection. Aust N Z J Public Health. (2002) 26:3435. 10.1111/j.1467-842X.2002.tb00182.x

  • 44.

    OleasRPuga-TejadaMSánchez-CarrielMValeroMMartin-DelgadoJOspinaJet al. Spanish translation and validation of a hybrid, health-related quality of life questionnaire for chronic esophageal conditions: NEQOL-S. Neurogastroenterol Motil. (2022) 3:12. 10.1111/nmo.14511

  • 45.

    Molina-TorresGGuallar-BoulocMGalán-MercantAKasper-JedrzejewskaMMerchán-BaezaJAGonzalez-SanchezM. Spanish cross-cultural adaptation and validation of the Australian pelvic floor questionnaire in running women. Sci Rep. (2022) 12:8325. 10.1038/s41598-022-12043-5

  • 46.

    Peinado-MolinaRAPeinado-MolinaMDMolina-IbañezMDMartínez-GalianoJM. Association between non-competitive physical exercise and menstrual disorders. Afr J Reprod Health. (2020) 24:816. 10.29063/ajrh2020/v24i1.8

  • 47.

    ZhuZZhuDJiangYLinYYangYLuanW. Cross-sectional study on the SF-36, the general self- efficacy, the social support, and the health promoting lifestyle of the young elderly in a community in Shanghai. Ann Palliat Med. (2021) 10:51829. 10.21037/apm-20-2462

  • 48.

    MishraGDHockeyRDobsonAJA. comparison of SF-36 summary measures of physical and mental health for women across the life course. Qual Life Res. (2014) 23:151521. 10.1007/s11136-013-0586-3

  • 49.

    HuangHYTsaiWCChouWYHungYCLiuLCHuangKFet al. Quality of life of breast and cervical cancer survivors. BMC Womens Health. (2017) 17:30. 10.1186/s12905-017-0387-x

  • 50.

    García-MendizábalMJCarrascoJMPérez-GómezBAragonésNGuallar-CastillónPRodríguez-ArtalejoFet al. Role of educational level in the relationship between Body Mass Index (BMI) and health-related quality of life (HRQL) among rural Spanish women. BMC Public Health. (2009) 9:120. 10.1186/1471-2458-9-120

  • 51.

    WarkentinLMMajumdarSRJohnsonJAAgborsangayaCBRueda-ClausenCFSharmaAMet al. Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: 2-year prospective cohort study. BMC Med. (2014) 12:175. 10.1186/s12916-014-0175-5

  • 52.

    AnJNyarkoEHamadMA. Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis. Clin Rheumatol. (2019) 38:271726. 10.1007/s10067-019-04613-2

  • 53.

    Ulibarri-OchoaA. Ruiz-de-Alegría B, López-Vivanco G, García-Vivar C, Iraurgi I. Differences in quality of life and emotional well-being in breast, colon, and lung cancer patients during outpatient adjuvant chemotherapy: a longitudinal study. Cancer Nurs. (2022) 4:21. 10.1097/NCC.0000000000001070

  • 54.

    Alonso-MoleroJDierssen-SotosTGomez-AceboIFernandez de Larrea BazNGuevaraMAmianoPet al. Quality of life in a cohort of 1078 women diagnosed with breast cancer in spain: 7-year follow-up results in the MCC-Spain study. Int J Environ Res Public Health. (2020) 17:8411. 10.3390/ijerph17228411

  • 55.

    TangNKYFiecasMAfolaluEFWolkeD. Changes in sleep duration, quality, and medication use are prospectively associated with health and wellbeing: analysis of the UK household longitudinal study. Sleep. (2017) 40:79. 10.1093/sleep/zsw079

  • 56.

    DostálováRStillmanCEricksonKISlepičkaPMudrákJ. The relationship between physical activity, self-perceived health, and cognitive function in older adults. Brain Sci. (2021) 11:492. 10.3390/brainsci11040492

  • 57.

    KaletaDMakowiec-DabrowskaTDziankowska-ZaborszczykEJegierA. Physical activity and self-perceived health status. Int J Occup Med Environ Health. (2006) 19:1. 10.2478/v10001-006-0005-x

  • 58.

    CovertECBakerAMGilaniO. Evaluating clinical and demographic influences on health perception: a translation of the SF-12 for use with NHANES. SSM Popul Health. (2022) 18:101081. 10.1016/j.ssmph.2022.101081

  • 59.

    LeraLMárquezCSaguezRMoyaMOAngelBAlbalaC. Calidad de vida en personas mayores con depresión y dependencia funcional: validez del cuestionario SF-12. Rev Med Chil. (2021) 149:1292301. 10.4067/S0034-98872021000901292

  • 60.

    NilesANSherbourneCDRoy-ByrnePPSteinMBSullivanGBystritskyAet al. Anxiety treatment improves physical functioning with oblique scoring of the SF-12 short form health survey. Gen Hosp Psychiatry. (2013) 35:2916. 10.1016/j.genhosppsych.2012.12.004

  • 61.

    AhangariA. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. (2023) 17:E1417. 10.36076/ppj.2014/17/E141

Summary

Keywords

pelvic floor disorders, quality of life, women's health, pelvic floor, women's health services

Citation

Peinado Molina RA, Hernández Martínez A, Martínez Vázquez S and Martínez Galiano JM (2023) Influence of pelvic floor disorders on quality of life in women. Front. Public Health 11:1180907. doi: 10.3389/fpubh.2023.1180907

Received

02 June 2023

Accepted

25 September 2023

Published

24 October 2023

Volume

11 - 2023

Edited by

Roberta Tutino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Italy

Reviewed by

Andrea Chisari, Azienda Sanitaria Provinciale di Catania, Italy; Thomas G. Gray, Norfolk and Norwich University Hospital, United Kingdom

Updates

Copyright

*Correspondence: Sergio Martínez Vázquez

†ORCID: Rocío Adriana Peinado Molina orcid.org/0000-0003-3543-5170

Antonio Hernández Martínez orcid.org/0000-0002-9100-1134

Sergio Martínez Vázquez orcid.org/0000-0002-8752-459X

Juan Miguel Martínez Galiano orcid.org/0000-0002-0878-8635

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics